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Introduction {#sec001}
============

The current novel coronavirus outbreak, COVID-19, has spread across the globe with hundreds of thousands infected and thousands of deaths. \[[@pone.0231808.ref001]\] At the time of this writing (March 25, 2020), there are over 54,000 cases of COVID-19 in the US with 737 deaths. \[[@pone.0231808.ref002]\] With COVID-19 now declared a pandemic by the World Health Organization, \[[@pone.0231808.ref003]\] it is important to understand risk perceptions about COVID-19 and trust in political and public health/scientific leadership among the US population to better inform messaging and policies. \[[@pone.0231808.ref004]\]

Objective {#sec002}
---------

In the first study of its kind on COVID-19, our objective was to survey the adult US population to better understand their risk perceptions about the COVID-19 outbreak.

Methods {#sec003}
=======

Data were collected using an electronic questionnaire via Qualtrics® (Qualtrics, Provo, UT). Participants completed the questionnaire through the CloudResearch \[[@pone.0231808.ref005]\] online platform in early February 2020. We asked participants to rank who they felt should lead the US response to COVID-19. Options included the president, Congress, the Director of the Centers for Disease Control and Prevention (CDC), and the Director for the National Institutes of Health (NIH; [S1 Survey](#pone.0231808.s001){ref-type="supplementary-material"}). In addition, participants completed the perceived risk scale (Cronbach's α = 0.71) which had 10 survey-items (5-point Likert Scale: 0 = strongly disagree/disagree/neutral; 1 = agree/strongly agree). We also asked about their support for restrictive infection prevention policies and the reliability of various sources of information ([S1 Survey](#pone.0231808.s001){ref-type="supplementary-material"}). Descriptive analyses were conducted. Yale University Institutional Review Board approved this study (IRB protocol number: 2000027402). Participants provided informed consent prior to data collection.

Results {#sec004}
=======

The sample consisted of 718 adults and was similar to the US population in terms of age, gender, race, ethnicity, and education ([Table 1](#pone.0231808.t001){ref-type="table"}).

10.1371/journal.pone.0231808.t001

###### Demographic characteristics of sample compared to US population.

![](pone.0231808.t001){#pone.0231808.t001g}

                                                       Total (N = 718) n (%)   US Population[\*](#t001fn001){ref-type="table-fn"} (%)
  ---------------------------------------------------- ----------------------- --------------------------------------------------------
  Gender                                                                       
          Male                                         330 (46)                49
          Female                                       386 (54)                51
          Other                                        2 (0)                   
  Age (years)[\*\*](#t001fn002){ref-type="table-fn"}                           
          18--25                                       84 (12)                 12
          26--35                                       145 (20)                18
          36--45                                       166 (23)                16
          46--55                                       111 (15)                17
          55+                                          212 (30)                36
  Race                                                                         
          Black/African American                       111 (15)                13
          American Indian/Alaska Native                35 (5)                  1
          Asian                                        69 (10)                 5
          Native Hawaiian/Other Pacific Islander       2 (0)                   0
          White                                        501 (70)                73
  Ethnicity                                                                    
          Hispanic                                     107 (15)                18
          Non-Hispanic                                 611 (85)                82
  Education                                                                    
          No high school                               6 (1)                   12
          High school                                  182 (25)                27
          Some College                                 174 (24)                29
          College                                      223 (31)                19
          Graduate/Professional                        133 (19)                12

\*American Community Survey 2018 (5-year estimate)

\*\* Percentages are out of total population 18 years and older

Over 90% of our sample was aware of the COVID-19 mostly through the news (n = 522, 73%). The majority of participants wanted the CDC Director (n = 382, 53%) or the NIH Director (n = 117, 16%) to lead the COVID-19 response ([Fig 1](#pone.0231808.g001){ref-type="fig"}). However, only a small percentage of participants wanted the president (n = 91, 13%) or Congress (n = 5, 1%) to lead the response ([Fig 1](#pone.0231808.g001){ref-type="fig"}).

![Participants choice for who should lead the US response to COVID-19 outbreak.](pone.0231808.g001){#pone.0231808.g001}

The mean risk perception score was 5.0 out of 10 (*SD* = 1.9; [Fig 2](#pone.0231808.g002){ref-type="fig"}). Strict policies for infection prevention including quarantine (n = 571, 83%) and travel restriction (n = 519, 75%) were endorsed by most participants. Additionally, thirty-five percent of participants supported "temporary discrimination based on someone's country of origin" in case of an outbreak (n = 244, 35%).

![Distribution of risk perception score.](pone.0231808.g002){#pone.0231808.g002}

The most trusted sources of information for the participants were healthcare professionals (*M* = 4.3; *SD* = 0.9) and health officials (e.g. CDC and NIH; *M* = 4.2; *SD* = 1.0). The least trusted source of information was social media (*M* = 2.8; *SD* = 1.2; [Fig 3](#pone.0231808.g003){ref-type="fig"}).

![Participants confidence in various information sources.](pone.0231808.g003){#pone.0231808.g003}

Over 90% of the participants correctly identified CDC-recommended \[[@pone.0231808.ref006]\] infection prevention measures ([Fig 4](#pone.0231808.g004){ref-type="fig"}).

![Participants correctly identifying effective infection prevention measures for themselves/others.](pone.0231808.g004){#pone.0231808.g004}

Discussion {#sec005}
==========

We found that the public trusted the CDC Director to lead the COVID-19 response with trust in the public health/scientific leadership being high. Responsive, open, and respectful communication with the US population by these agencies may improve public health compliance and safety. \[[@pone.0231808.ref003]\] Furthermore, although participants reported relatively low risk perception, many supported restrictive policies for infection prevention. A portion of the sample also supported temporary discrimination based on someone's country of origin. These responses are concerning, and preemptive targeted messaging by the public health agencies is required to ensure a compassionate response to this outbreak. Our findings may be influenced by possible selection bias because participants needed a CloudResearch account and access to smartphone/computer to participate. However, our sample was fairly representative of the general adult US population. A weighted analysis based on age and gender demonstrate that our results are generalizable to national population ([Table 2](#pone.0231808.t002){ref-type="table"}). Data for weighted analysis were extracted from US Census data. \[[@pone.0231808.ref007]\]

10.1371/journal.pone.0231808.t002

###### Comparison of sample result to weighted result based on age and gender.

![](pone.0231808.t002){#pone.0231808.t002g}

                                                    Sample Result   Weighted Result
  ------------------------------------------------- --------------- -----------------
  Risk Perception Score (mean)                      5.0             5.0
  Confidence in Sources of Information (mean)                       
          Healthcare Professionals                  4.3             4.3
          CDC/NIH                                   4.2             4.2
          TV                                        3.7             3.6
          Print                                     3.5             3.4
          Web                                       3.4             3.4
          Friends/Family                            3.0             3.0
          Social Media                              2.8             2.8
  Who should lead the US response to COVID-19 (%)                   
          Director of CDC                           53.2            52.3
          Director of NIH                           16.3            16.6
          President                                 12.7            13.5
          Secretary of DHHS                         9.3             9.6
          State Departments of Health               3.5             3.4
          Local Health Departments                  2.8             2.5
          Congress                                  0.7             0.6

Conclusion {#sec006}
==========

Given our results, the public health/scientific leadership should be at the forefront of the COVID-19 response to promote trust. Strategic messaging by the CDC and the NIH through television, print, and internet has strong potential to alleviate unnecessary fear among the US population.

Supporting information {#sec007}
======================

###### Perceptions regarding the novel coronavirus outbreak questionnaire.

(DOCX)

###### 

Click here for additional data file.

###### 

(XLSX)

###### 

Click here for additional data file.

###### 

(XLS)

###### 

Click here for additional data file.
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Reviewer 1:

1\. In abstract line 1: please add Coronavirus Disease 2019 as a definition for COVID-19.

Response: The sentence has been revised as requested. The sentence now reads as follows:

"The Coronavirus Disease 2019 (COVID-19) outbreak is spreading globally." (line 20)

2\. In abstract line 2: the risk of infection in US, I think now changed to high due to pandemic declaration (also amend in all manuscript).
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"Although COVID-19 has now been declared a pandemic and risk for infection in the United States (US) is currently high, at the time of survey administration the risk of infection in the US was low." (lines 20 -- 22)

3\. In Background page 3, line 1: the countries infected by COVID-19 need update according to the latest WHO report (not 28 countries).
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"At the time of this writing (March 25, 2020), there are over 54,000 cases of COVID-19 in the US with 737 deaths (2).With COVID-19 now declared a pandemic by the World Health Organization (3), it is important to understand risk perceptions about COVID-19 and trust in political and public health/scientific leadership among the US population to better inform messaging and policies (4)." (Lines 40 -- 44)

5\. In page 5 and 6, Figure 1, 2: there are no error bars and the statistically significant marks, also describe the statistical parameters used in analysis (type parameters in Legends).

Response: We have added the error bars to figures 1,2 and 4 and revised figure 3 so that all error bars now show SE and are consistent. As the objective of this study was to provide descriptive data on the perceptions of the US population, we did not carry out any inferential statistical testing and hence do not have a statistically significant marks on the figures to report.
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